The NHLI is the UK's largest heart and lung institute undertaking world-leading research into all aspects of cardiac, respiratory and vascular science. Through this, we aim to develop better treatment and understanding of common conditions of the heart and lung.
Imperial is the top university in the UK in three specialities; respiratory, cardiovascular and gastroenterology"
The Rand analysis (2004-2013)
In the latest assessment of research quality at UK institutions (REF 2014) Imperial College Lonon was rated third in the UK overall in Clinical Medicine, and top in Respiratory Medicine. The NHLI has a proud history of undertaking cutting edge research covering fundamental basic science through to clinical trials and implementation; it has the privilege to partner with several major hospitals in West London including the Royal Brompton and Harefield, Hammersmith and St Mary’s Hospitals, all with exceptionally strong clinical cardiac and respiratory medicine programmes. Current and past staff working in the NHLI include Professor Dame Margaret Turner-Warwick, Professor Peter Barnes FRS, Professor James Scott FRS, Professor Sir Magdi Yacoub FRS, OM and Professor Sir Malcolm Green.
The NHLI Strategic Plan 2019-2024 outlines the current ambitions of the Institute.
Research overview and highlights
Respiratory research at Imperial College London
NHLI's respiratory focused research sections include Airways Disease; Cardio Respiratory Interface; Genomic and Environmental Medicine; Inflammation, Repair and Development and Respiratory Infections.
Respiratory research at Imperial College London
Our Respiratory Medicine group has the largest critical mass of respiratory researchers in the UK
NHLI's respiratory focused research sections include Airways Disease; Cardio Respiratory Interface; Genomic and Environmental Medicine; Inflammation, Repair and Development and Respiratory Infections.
Cardiovascular research at Imperial College London
Imperials's research in cardiovascular science is focused within the NHLI
Imperial's research in cardiovascular science is focused within the National Heart and Lung Institute (NHLI) which is at the forefront of the diagnosis, prevention and treatment of heart disease.
BREATHE - The HDR Hub for Respiratory Health
Dr Jennifer Quint is co-director of HDR UK's hub using data to tackle respiratory disease.
Dr Jennifer Quint is Deputy Director and Clinical Lead of the Respiratory Hub ‘BREATHE’, that is headed by the University of Edinburgh. The data hubs based across the UK aim to give patients faster access to pioneering treatments.
What is mesothelioma?
The National Centre for Mesothelioma Research investigates mesothelioma.
The UK has the highest incidence of mesothelioma in the world. This aggressive form of cancer results in 2,500 deaths a year in the UK, and it is estimated that there will be 50,000 to 60,000 new cases by 2050. Mesothelioma is so prevalent in the UK in part due to the use of asbestos not being reduced earlier and our legacy of a large shipbuilding industry.
Find out more about the National Centre for Mesothelioma Research.
